Detalhe da pesquisa
1.
Individualized Antisense Oligonucleotide Therapies: How to Approach the Challenge of Manufacturing These Oligos from a Chemistry, Manufacturing, and Control-Regulatory Standpoint.
Nucleic Acid Ther
; 32(2): 101-110, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962152
2.
Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
Biochemistry
; 49(47): 10166-78, 2010 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21028906
3.
Local RNA target structure influences siRNA efficacy: a systematic global analysis.
J Mol Biol
; 348(4): 871-81, 2005 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-15843019
4.
Stereocontrolled Oligonucleotides for Nucleic Acid Therapeutics: A Perspective.
Nucleic Acid Ther
; 31(1): 1-6, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305971
5.
Inhibition of hepatitis B virus replication in vivo using lipoplexes containing altritol-modified antiviral siRNAs.
Artif DNA PNA XNA
; 1(1): 17-26, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21687523
6.
Oligodeoxynucleotides containing N1-methyl-2'-deoxyadenosine and N6-methyl-2'-deoxyadenosine.
Curr Protoc Nucleic Acid Chem
; Chapter 4: Unit 4.36 1-19, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19746356